Announcements Trials
Browse Landscape

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 56Carcinoma, Non-Small-Cell Lung 35Breast Neoplasms 29Neoplasm Metastasis 23Glioblastoma 23Colonic Neoplasms 23Rectal Neoplasms 19Ovarian Neoplasms 16Neoplasms 15Brain Neoplasms 12Lung Neoplasms 11Pancreatic Neoplasms 10Glioma 10Fallopian Tube Neoplasms 10Carcinoma, Renal Cell 10Carcinoma, Hepatocellular 9Gliosarcoma 7Adenocarcinoma of Lung 7Kidney Neoplasms 6Liver Neoplasms 5Astrocytoma 5Sarcoma 4Recurrence 4Oligodendroglioma 4Melanoma 4Uterine Cervical Neoplasms 3Lymphoma, Non-Hodgkin 3Leukemia, Myeloid, Acute 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2

Interventions

pazopanib 1ganirelix 1benazepril 1Ramipril 1Preventive Health Services 1Observation 1Methyltestosterone 1Losartan 1Lisinopril 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Fatty Acids, Omega-3 1Desvenlafaxine Succinate 1Bevacizumab 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Hypertension × Bevacizumab × Clear all
NCT00674011 2014-05-06

Hypertension in Breast Cancer Patients Receiving Bevacizumab

Dana-Farber Cancer Institute

Terminated
10 enrolled
Breast

Breast Neoplasms, Hypertension

Data powered by HemOnc (CC BY 4.0) Colophon âš¡